0001213900-21-058901 | 10-Q | XBRL Viewer | Ayala Pharmaceuticals INC

Tax (Details) - Schedule of unrecognized tax benefits - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
Sep. 30, 2021	Sep. 30, 2021
Schedule of unrecognized tax benefits [Abstract]
Additions for tax positions of current year	$ (14)	$ 297

Print Document View Excel Document
Notes Details Tax (Details) - Schedule of unrecognized tax benefits Uncategorized Uncategorized Items - f10q0921_ayalapharma_htm.xml All Reports

Label	Element	Value
IssuancesOfSharesNetOfIssuanceCosts	ayla_IssuancesOfSharesNetOfIssuanceCosts	$ 337,000
IssuancesOfSharesNetOfIssuanceCosts	ayla_IssuancesOfSharesNetOfIssuanceCosts	$ 337,000
IssuanceOfSharesNetOfIssuanceCosts	ayla_IssuanceOfSharesNetOfIssuanceCosts	442,407
IssuanceOfSharesNetOfIssuanceCosts	ayla_IssuanceOfSharesNetOfIssuanceCosts	442,407
RestrictedBankDepositsInOtherAssets	ayla_RestrictedBankDepositsInOtherAssets	$ 224,000
RestrictedBankDepositsInOtherAssets	ayla_RestrictedBankDepositsInOtherAssets	236,000
NoncashDeferredIssuanceCosts	ayla_NoncashDeferredIssuanceCosts	156,000
NoncashDeferredIssuanceCosts	ayla_NoncashDeferredIssuanceCosts	250,000
StockIssuanceCostIncurredButNotYetPaid	ayla_StockIssuanceCostIncurredButNotYetPaid	$ 231,000
PeriodBeforeWhichBreachShallBeCuredByTheLicense	ayla_PeriodBeforeWhichBreachShallBeCuredByTheLicense	60 days
IssuanceOfSharesAndWarrantsNet	ayla_IssuanceOfSharesAndWarrantsNet	$ 23,322,000
IssuanceOfSharesAndWarrantsNet	ayla_IssuanceOfSharesAndWarrantsNet
PeriodForWhichLicenseOptionGrantedShallRemainUncured	ayla_PeriodForWhichLicenseOptionGrantedShallRemainUncured	36 months
IssuanceOfCommonStockInitialPublicOfferingNetOfIssuanceCosts	ayla_IssuanceOfCommonStockInitialPublicOfferingNetOfIssuanceCosts	$ 2,835,000
BankGuaranteeObtainedForLeaseAgreement	ayla_BankGuaranteeObtainedForLeaseAgreement	$ 200,000
PeriodBeforeWhichBreachShallBeCuredByTheCompany	ayla_PeriodBeforeWhichBreachShallBeCuredByTheCompany	60 days
PaymentsOfStockAndWarrantsIssuanceCosts	ayla_PaymentsOfStockAndWarrantsIssuanceCosts	$ 1,665,000
CollaborativeArrangementMilestonePayments	ayla_CollaborativeArrangementMilestonePayments	$ 95,000,000
NoticePeriodForTerminationOfTheAgreement	ayla_NoticePeriodForTerminationOfTheAgreement	60 days
CollaborativeArrangementAdditionalMilestonePaymentsLiability	ayla_CollaborativeArrangementAdditionalMilestonePaymentsLiability	$ 47,000,000
StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants	ayla_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants	333,333
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalent	ayla_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalent	$ 41,184,000
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalent	ayla_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalent	49,069,000
TotalGrossProceeds	ayla_TotalGrossProceeds	3,000,000
CollaborativeArrangementsSalesBasedMilestoneAmountPayable	ayla_CollaborativeArrangementsSalesBasedMilestoneAmountPayable	$ 50,000,000
TermOfLicenseAgreement	ayla_TermOfLicenseAgreement	10 years
TermOfLicenseAgreement	ayla_TermOfLicenseAgreement	10 years
PeriodForWhichLicenseOptionGrantedShallRemainEffective	ayla_PeriodForWhichLicenseOptionGrantedShallRemainEffective	60 days
AmortizationOfDeferredRentLiability	ayla_AmortizationOfDeferredRentLiability	$ 60,000
AmortizationOfDeferredRentLiability	ayla_AmortizationOfDeferredRentLiability
MilestonePaymentReceivable	ayla_MilestonePaymentReceivable	245,000,000
AggregateOfferingPrice	ayla_AggregateOfferingPrice	200,000,000
SalesAgreementMember
TotalGrossProceeds	ayla_TotalGrossProceeds	6,200,000
TwoThousandAndTwentyOneInvestorsPurchaseAgreementMemberMember
CommonStockSharesAndWarrantsSubscribedButNotIssuedValue	ayla_CommonStockSharesAndWarrantsSubscribedButNotIssuedValue	4,999,995
ClassOfWarrantsOrRightsSubscribedButNotIssuedValue	ayla_ClassOfWarrantsOrRightsSubscribedButNotIssuedValue	$ 19,986,661.67
ClassOfWarrantsOrRightsSubscribedButNotIssued	ayla_ClassOfWarrantsOrRightsSubscribedButNotIssued	466,666